Stay updated on NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial page.

Latest updates to the NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check10 days agoChange DetectedThe clinical trial record is now available with its study design, treatments, outcomes, eligibility criteria, locations, results-related information, publications, and study documents. It states that the study was terminated after a futility analysis and is no longer seeking participants.SummaryDifference100%

- Check17 days agoChange DetectedThe footer's revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check31 days agoChange DetectedA notice about NIH’s terminology transition appears above the 403 Forbidden message, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check45 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedA 403 Forbidden error is displayed on the page, indicating the study record is temporarily inaccessible and the page content cannot be loaded.SummaryDifference18%

Stay in the know with updates to NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NUC-1031 vs Gem/Cis in Advanced Biliary Tract Cancer Clinical Trial page.